Watch PriorityDeveloping
Definium Therapeutics' LSD-Based Drug Shows Promise in Mid-Stage Trial, Stocks Surge
worth trackingUpdated 3h ago
Key takeaway: The successful results of Definium's clinical trial for its LSD-based drug DT120 not only highlight the potential of psychedelics in treating depression but may also reshape regulatory landscapes surrounding mental health therapies.
